April 16, 2023
2 mins read

Implantable device shrinks pancreatic tumours

The result, published in Advanced Science, found in murine models, was tumour reduction at a four-fold lower dosage than traditional systemic immunotherapy treatment….reports Asian Lite News

Researchers have found a way to tame pancreatic cancer – one of the most aggressive and difficult to treat cancers – by delivering immunotherapy directly into the tumour with a device that is smaller than a grain of rice.

The team from Houston Methodist Research Institute in the U.S. used an implantable nanofluidic device they invented to deliver CD40 monoclonal antibodies (mAb), a promising immunotherapeutic agent, at a sustained low-dose via the nanofluidic drug-eluting seed (NDES).

The NDES device consists of a stainless-steel drug reservoir containing nanochannels, thus creating a membrane that allows for sustained diffusion when the drug is released.

The result, published in Advanced Science, found in murine models, was tumour reduction at a four-fold lower dosage than traditional systemic immunotherapy treatment.

“One of the most exciting findings was that even though the NDES device was only inserted in one of two tumours in the same animal model, we noted shrinkage in the tumour without the device,” said Corrine Ying Xuan Chua, Assistant Professor of nanomedicine at Houston Methodist Academic Institute.

“This means that local treatment with immunotherapy was able to activate the immune response to target other tumours. In fact, one animal model remained tumour-free for the 100-days of continued observation.”

Pancreatic ductal adenocarcinoma is frequently diagnosed at advanced stages. In fact, about 85 per cent of patients already have metastatic disease at diagnosis.

Immunotherapy holds promise in treating cancers that previously did not have good treatment options. However, because immunotherapy is delivered throughout the entire body, it causes many side effects that are sometimes long-lasting, if not life-long.

By focusing the delivery directly into the tumour, the body is protected from being exposed to toxic drugs and fewer side effects, essentially allowing patients undergoing treatment to have a better quality of life.

“Our goal is to transform the way cancer is treated. We see this device as a viable approach to penetrating the pancreatic tumour in a minimally invasive and effective manner, allowing for a more focused therapy using less medication,” said Alessandro Grattoni, chair of the Department of Nanomedicine at Houston Methodist Research Institute.

ALSO READ: ‘Crypto Assets requires immediate attention from G20’

Previous Story

‘Will not tolerate Indian High Commission attack’

Next Story

Apple shipped $7.5 bn worth gadgets in India

Latest from Business

‘India’s Digital Hub Ascends’

The event also featured discussions on the Quad Partnership for Cable Connectivity and Resilience, reiterating commitments made during the July 1 Quad Foreign Ministers’ Meeting India’s growing role as a key digital

India’s Job Market Surges

With hiring levels on the rise, compensation is expected to increase by 12-15% in metro cities and by 18-22% in emerging cities India’s festive season this year is poised to create more

India Inc Eyes Upswing

Private equity (PE) remained comparatively stable in Q2, clocking 357 deals worth $7.4 billion — the second-highest volume since Q4 2022. However, deal values dipped on a quarter-on-quarter basis due to the

Apple Appoints Sabih Khan as New COO

Khan will take over from Jeff Williams, who is stepping down from the role this month and will retire later this year…reports Asian Lite News Apple has announced that Sabih Khan, an
Go toTop